Xin-rong H. Yang
Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Tumor regression grade for prognosis of patients with colorectal cancer liver metastasis undergoing conversion therapy
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: June 24, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 30, 2026
Correction: Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.
Journal: Molecular cancer
Published: March 18, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.
Journal: The New England journal of medicine
Published: March 04, 2026
Integration of Chelex-100 thermal lysis and lyophilized LAMP for rapid point-of-care detection of surgical site infections following liver surgery.
Journal: Analytica chimica acta
Published: November 05, 2025
Multi-omic profiling identifies TREM2+ lipid-laden macrophages as inflammatory drivers and therapeutic targets of colorectal cancer liver metastasis.
Journal: Cancer letters
Published: September 14, 2025
Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis.
Journal: Journal of gastrointestinal oncology
Published: August 14, 2025
Erratum: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.
Journal: Hepatology (Baltimore, Md.)
Published: August 14, 2025
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response.
Journal: Cancer letters
Published: July 16, 2025
The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.
Journal: Journal of hematology & oncology
Published: June 25, 2025
Last Updated: 09/26/2026